Oxford Biomedical Technologies

Oxford Biomedical Technologies is renowned for its pioneering work in the field of diet-induced inflammation, therapy, training, and technology development. Central to their work is the patented Mediator Release Test (MRT®) and the proprietary LEAP (Lifestyle Eating And Performance) anti-inflammatory eating plans. The company's expertise is backed by a strong record of innovation, having authored several U.S. and international patents related to diet-induced inflammation technology.

The Mediator Release Test (MRT®) is a key offering from Oxford Biomedical Technologies. This test quantifies the inflammatory response to foods and food chemicals, helping in the diagnosis and management of various conditions like IBS, migraines, and fibromyalgia that are affected by diet-induced inflammation. MRT® operates on the principle that the release of mediators like cytokines and histamine from white blood cells is the primary cause of negative effects in food-sensitivity sufferers. This makes MRT a functional test that measures diet-induced sensitivity pathways and provides invaluable clinical information for effective treatment.

Oxford Biomedical Technologies also developed the LEAP Program to implement the findings from MRT® in a practical way. LEAP is not just a diet plan; it was developed and refined in a clinical setting and focuses on creating patient-specific anti-inflammatory eating plans. This approach has shown remarkable efficacy in providing fast and reliable relief from the effects of diet-induced inflammation.

Additionally, recognizing the gap in practitioner training in this area, Oxford Biomedical Technologies offers a Certified LEAP Therapist training course. This course is designed to equip dietetic professionals with comprehensive knowledge about different types of adverse food reactions, emphasizing the role of diet-induced inflammation in various chronic conditions.

Through these innovations, Oxford Biomedical Technologies has positioned itself as a leader in addressing diet-induced inflammatory issues, offering both diagnostic and therapeutic solutions to healthcare practitioners and patients.

Oxford Biomedical Technologies

All Laboratories